tobramycin has been researched along with Bacterial Conjunctivitides in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.56) | 18.7374 |
| 1990's | 5 (27.78) | 18.2507 |
| 2000's | 4 (22.22) | 29.6817 |
| 2010's | 8 (44.44) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Borgman, CJ | 1 |
| Grace, SF; Olson, DJ; Taggart, M; Ward, MF | 1 |
| Asbell, PA; DeCory, HH | 1 |
| Bianchi, PE; Bremond-Gignac, D; Chiambaretta, F; Delval, L; Hartani, D; Kaercher, T; Kocyla-Karczmarewicz, B; Lazreg, S; Messaoud, R; Murta, J; Nezzar, H; Renault, D; Speeg-Schatz, C; Voinea, L | 1 |
| Beresniak, A; Bhagat, Y; Bingen, E; Bremond-Gignac, D; Cochereau, I; Delval, L; El Fekih, L; Goldschmidt, P; Mariani-Kurkdjian, P; Pouliquen, P | 1 |
| Amraoui, A; Bhagat, Y; Bourcier, T; Cochereau, I; Khairallah, M; Meddeb-Ouertani, A; Pop, M; Robert, PY; Zaghloul, K | 1 |
| Alfonso, EC; Almeida, DR; Miller, D | 1 |
| Cockrum, P; Hammonds, WM; Meier, E; Silverstein, B; Silverstein, S; Torkildsen, GL | 1 |
| Alvarez, MS; Brancaccio, RR | 1 |
| Amraoui, A; Bourcier, T; Cochereau, I; Delval, L; Garg, P; Goldschmidt, P; Khairallah, M; Meddeb-Ouertani, A; Pop, M; Pouliquen, P; Tandon, R; Zaghloul, K | 1 |
| Abelson, M; Bowman, L; Protzko, E; Shapiro, A | 1 |
| Kovács, B; Krassói, E | 1 |
| Carr, JD; Godfrey, DG; Grossniklaus, HE | 1 |
| Carstocea, B; Chercota, G; Gafencu, O; Milazzo, G; Papa, V; Rodica, P; Santocono, M | 1 |
| Bonini, S; Bonomi, L; Bucci, MG; Bujtar, E; Colangelo, L; Curatola, MR; Damiani, S; Della Loggia, G; Gallenga, PE; Jauch, A; Lobefalo, L; Milan, E; Orzalesi, N; Pagliarusco, A; Palma, LA; Ponte, F; Tomazzoli Gerosa, L; Velati, P | 1 |
| Dattani, D; Jackson, WB; Leeder, RG; Low, DE; MacDougall, R; Whitsitt, PF | 1 |
| Gwon, A | 1 |
| Call, NB; Dirks, MS; Jacobson, JA; Kasworm, EM; Turner, RB | 1 |
11 trial(s) available for tobramycin and Bacterial Conjunctivitides
| Article | Year |
|---|---|
Efficacy and safety of azithromycin 1.5% eye drops in paediatric population with purulent bacterial conjunctivitis.
Topics: Administration, Topical; Adolescent; Anti-Bacterial Agents; Azithromycin; Bacteria; Child; Child, Preschool; Conjunctivitis, Bacterial; Eye Infections, Bacterial; Female; Humans; Infant; Infant, Newborn; Male; Ophthalmic Solutions; Tobramycin; Treatment Outcome | 2014 |
Efficacy and safety of azithromycin 1.5% eye drops for purulent bacterial conjunctivitis in pediatric patients.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Azithromycin; Bacteria; Child; Child, Preschool; Conjunctivitis, Bacterial; Female; Humans; Infant, Newborn; Male; Ophthalmic Solutions; Tobramycin; Treatment Outcome; Young Adult | 2010 |
[Efficacy assessment of azithromycin 1.5% eye drops versus tobramycin 0.3% on clinical signs of purulent bacterial conjunctivitis].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Azithromycin; Child; Child, Preschool; Conjunctiva; Conjunctivitis, Bacterial; Edema; Erythema; Eyelid Diseases; Follow-Up Studies; Humans; Hyperemia; Infant; Infant, Newborn; Middle Aged; Ophthalmic Solutions; Safety; Single-Blind Method; Suppuration; Tobramycin; Treatment Outcome; Young Adult | 2010 |
Evaluation of clinical efficacy and safety of tobramycin/dexamethasone ophthalmic suspension 0.3%/0.05% compared to azithromycin ophthalmic solution 1% in the treatment of moderate to severe acute blepharitis/blepharoconjunctivitis.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Inflammatory Agents; Azithromycin; Blepharitis; Conjunctivitis, Bacterial; Dexamethasone; Drug Combinations; Female; Humans; Instillation, Drug; Male; Middle Aged; Ophthalmic Solutions; Osmolar Concentration; Tobramycin; Treatment Outcome; Validation Studies as Topic | 2011 |
3-day treatment with azithromycin 1.5% eye drops versus 7-day treatment with tobramycin 0.3% for purulent bacterial conjunctivitis: multicentre, randomised and controlled trial in adults and children.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Azithromycin; Child; Child, Preschool; Conjunctivitis, Bacterial; Drug Administration Schedule; Female; Humans; Infant; Infant, Newborn; Male; Middle Aged; Ophthalmic Solutions; Single-Blind Method; Tobramycin; Treatment Outcome | 2007 |
Phase 3 safety comparisons for 1.0% azithromycin in polymeric mucoadhesive eye drops versus 0.3% tobramycin eye drops for bacterial conjunctivitis.
Topics: Adhesives; Adolescent; Adult; Aged; Anti-Bacterial Agents; Azithromycin; Child; Child, Preschool; Conjunctivitis, Bacterial; Female; Humans; Infant; Male; Middle Aged; Ophthalmic Solutions; Polymers; Prospective Studies; Tobramycin; Treatment Outcome; Visual Acuity | 2007 |
Topical netilmicin compared with tobramycin in the treatment of external ocular infection.
Topics: Administration, Topical; Adult; Anti-Bacterial Agents; Conjunctivitis, Bacterial; Double-Blind Method; Drug Resistance, Microbial; Female; Gentamicins; Humans; Male; Microbial Sensitivity Tests; Netilmicin; Staphylococcal Infections; Staphylococcus aureus; Tobramycin; Treatment Outcome | 1999 |
Topical lomefloxacin 0.3% twice daily versus tobramycin 0.3% in acute bacterial conjunctivitis: A multicenter double-blind phase III study.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Child; Colony Count, Microbial; Conjunctiva; Conjunctivitis, Bacterial; Double-Blind Method; Female; Fluoroquinolones; Follow-Up Studies; Haemophilus Infections; Humans; Male; Middle Aged; Ophthalmic Solutions; Prospective Studies; Quinolones; Staphylococcal Infections; Streptococcal Infections; Tobramycin; Treatment Outcome | 1999 |
Treatment of acute bacterial conjunctivitis: 1% fusidic acid viscous drops vs. 0.3% tobramycin drops.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Child; Child, Preschool; Conjunctivitis, Bacterial; Female; Fusidic Acid; Humans; Male; Middle Aged; Ophthalmic Solutions; Patient Compliance; Patient Satisfaction; Single-Blind Method; Tobramycin | 2002 |
Ofloxacin vs tobramycin for the treatment of external ocular infection. Ofloxacin Study Group II.
Topics: Blepharitis; Colony Count, Microbial; Conjunctiva; Conjunctivitis, Bacterial; Corneal Ulcer; Double-Blind Method; Eyelids; Humans; Microbiological Techniques; Ofloxacin; Ophthalmic Solutions; Tobramycin; Treatment Outcome | 1992 |
Safety and efficacy of topical norfloxacin versus tobramycin in the treatment of external ocular infections.
Topics: Administration, Topical; Adolescent; Adult; Aged; Aged, 80 and over; Blepharitis; Child; Child, Preschool; Clinical Trials as Topic; Conjunctiva; Conjunctivitis, Bacterial; Double-Blind Method; Eyelid Diseases; Eyelids; Female; Humans; Infant; Infant, Newborn; Male; Middle Aged; Multicenter Studies as Topic; Norfloxacin; Ophthalmic Solutions; Random Allocation; Tobramycin | 1988 |
7 other study(ies) available for tobramycin and Bacterial Conjunctivitides
| Article | Year |
|---|---|
Recurrent conjunctivitis secondary to Gram-positive bacillus, Bacillus thuringiensis.
Topics: Administration, Ophthalmic; Anti-Bacterial Agents; Bacillus thuringiensis; Conjunctivitis, Bacterial; Dexamethasone; Drug Therapy, Combination; Eye Infections, Bacterial; Glucocorticoids; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Moxifloxacin; Ophthalmic Solutions; Recurrence; Tobramycin | 2018 |
Morganella as a cause of ophthalmia neonatorum.
Topics: Anti-Bacterial Agents; Conjunctivitis, Bacterial; Enterobacteriaceae Infections; Female; Humans; Infant, Newborn; Morganella; Ophthalmia Neonatorum; Tobramycin; Treatment Outcome | 2018 |
Antibiotic resistance among bacterial conjunctival pathogens collected in the Antibiotic Resistance Monitoring in Ocular Microorganisms (ARMOR) surveillance study.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Anti-Bacterial Agents; Azithromycin; Child; Child, Preschool; Ciprofloxacin; Conjunctiva; Conjunctivitis, Bacterial; Drug Resistance, Multiple, Bacterial; Epidemiological Monitoring; Female; Haemophilus influenzae; Humans; Infant; Infant, Newborn; Male; Methicillin; Microbial Sensitivity Tests; Middle Aged; Oxacillin; Pseudomonas aeruginosa; Staphylococcus aureus; Streptococcus pneumoniae; Tobramycin; Trimethoprim; United States | 2018 |
Tsukamurella: an emerging opportunistic ocular pathogen.
Topics: Actinomycetales; Actinomycetales Infections; Aged, 80 and over; Anti-Bacterial Agents; Aza Compounds; Conjunctivitis, Bacterial; Drug Therapy, Combination; Female; Fluoroquinolones; Gentamicins; Humans; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Opportunistic Infections; Quinolines; Tobramycin | 2010 |
Periorbital dermatitis.
Topics: Aged; Aged, 80 and over; Conjunctivitis, Bacterial; Dermatitis, Allergic Contact; Drug Eruptions; Eyelid Diseases; Female; Follow-Up Studies; Humans; Ophthalmic Solutions; Patch Tests; Risk Assessment; Tobramycin | 2006 |
Use of Brulamycin (tobramycin) eye drops in the preoperative and postoperative treatment of ophthalmotomies.
Topics: Aged; Conjunctivitis, Bacterial; Female; Humans; Male; Ophthalmic Solutions; Ophthalmologic Surgical Procedures; Postoperative Complications; Premedication; Tobramycin | 1994 |
Epibulbar allergic granulomatous nodules in a human immunodeficiency virus-positive patient.
Topics: Adult; Biopsy; CD4 Lymphocyte Count; Conjunctival Diseases; Conjunctivitis, Bacterial; Cornea; Corneal Diseases; Dexamethasone; Granuloma; HIV Seropositivity; Humans; Male; Penicillin G; Streptococcal Infections; Tobramycin | 1998 |